Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;3(1):149-153.
doi: 10.3892/etm.2011.366. Epub 2011 Oct 14.

microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3

Affiliations

microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3

Jaeku Kang et al. Exp Ther Med. 2012 Jan.

Abstract

microRNAs (miRNAs) play a significant role in cancer development and progression by regulating the expression of proto-oncogenes or tumor suppressor genes. Our previous study using microarrays demonstrated that miR-99b was downregulated in patients with lung cancer. To assess whether or not miR-99b has a functional role in lung cancer, we determined the expression of miR-99b and fibroblast growth factor receptor 3 (FGFR3), which is a predicted target of miR-99b in public algorithms in human lung cancer tissues. miR-99b was downregulated and FGFR3 was upregulated in lung cancer patients. We demonstrated that the overexpression of miR-99b induced a reduction in FGFR3 expression and confirmed the target specificity between miR-99b and the FGFR3 3'-untranslated region by luciferase reporter assay. In addition, the growth rate in miR-99b precursor-treated cells was lower compared to the negative controls. Taken together, these results suggest that miR-99b may be a tumor suppressor through the downregulation of FGFR3. miR-99b may be a potent tumor suppressor and may be a potential therapeutic tool for patients with lung cancer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
miR-99b and FGFR3 expressions in the normal samples differed significantly from those in the lung cancer tissue samples. Real-time RT-PCR analysis of mature miR-99b and FGFR3 expression in lung cancer and normal lung tissues prepared from the same patients. *p= 0.0039, **p= 0. 015 versus control. FGFR3, fibroblast growth factor receptor 3; RT-PCR, reverse transcription polymerase chain reaction.
Figure 2.
Figure 2.
FGFR3 was regulated by miR-99b in lung cancer cells. (A) The signal from a luciferase reporter was significantly decreased at one miR-99b target site at the 3′UTR of FGFR3. *p<0.0001, versus control. (B) The effect of miR-99b on FGFR3 mRNA expression in lung cancer cells. *p<0.05 versus control. (C) The effect of miR-99b on HDAC1 protein expression in lung cancer cells. FGFR3, fibroblast growth factor receptor 3; RT-PCR, reverse transcription polymerase chain reaction; UTR, untranslated region.
Figure 3.
Figure 3.
miR-99b function as inhibitor of cell proliferation in lung cancer. Inhibitory effects of miR-99b on cell proliferation in H1299, HCC95 and HCC1438 cells. OD, optical density.
Figure 4.
Figure 4.
Anchorage-independent growth assay in H1299 cells. Results show the mean ± standard deviation (SD) of three independent experiments performed in triplicate. *p<0.05 versus control.

Similar articles

Cited by

References

    1. Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–355. - PubMed
    1. Kim VN, Nam J-W. Genomics of microRNA. Trends Genet. 2006;22:165–173. - PubMed
    1. Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31:37–49. - PMC - PubMed
    1. Kwak PB, Iwasaki S, Tomari Y. The microRNA pathway and cancer. Cancer Sci. 2010;101:2309–2315. - PMC - PubMed
    1. Volinia S, Calin GA, Liu C-G, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257–2261. - PMC - PubMed

LinkOut - more resources